文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

右侧结肠癌与左侧结肠癌患者血小板与淋巴细胞比值的临床基线和预后差异。

Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

机构信息

Sun Yat-sen University cancer center, 651 Dongfeng Road east, Guangzhou, 510060, China.

State Key Laboratory of Oncology in Southern China, Guangzhou, China.

出版信息

BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8.


DOI:10.1186/s12885-017-3862-8
PMID:29262803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5738180/
Abstract

BACKGROUND: Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ with respect to their biology and genomic patterns, but inflammatory index variation did not fully investigate. This study aimed to examine the difference of inflammatory indexes and its value between RCC and LCC. METHODS: The differences of common clinicopathologic factors, inflammatory indexes including PLR (Platelet lymphocyte ratio) between LCC and RCC were analyzed in the training cohort with logistic regression model, subsequently, confirmed in validation cohort. Kaplan-Meier analysis was applied for the analysis of the survival difference distinguished by the PLR and the Nonparametric Test was adopted to demonstrate the difference of PLR variation with the standard TNM classification between RCC and LCC. RESULTS: A total of 1846 CRC patients entered the study, 744 (40.3%) patients were RCC, 1102 (59.7%) were LCC. The patients' number in both cohorts was 923. It was found that LCC patients in the training cohort significantly to be with higher CEA, adenocarcinoma, early UICC/AJCC stage, p-MMR (mismatch-repair proficient), and lower PLR, and the later four features were confirm in validation cohort. Higher PLR, the unique inflammatory index, was significantly associated with poorer OS in LCC cohort (P = 0.002) and was elevated with the TNM stage in the LCC patients (P < 0.001), however, the two relationships did not sustain in RCC patients. CONCLUSION: Expect the classical characteristics, PLR, an inexpensive and easily assessable inflammatory index was found first time to be significant differ between LCC and RCC. Further, elevated PLR associated with poor OS (overall survival) in the LCC and more common in advanced TNM stage.

摘要

背景:右半结肠癌(RCC)和左半结肠癌(LCC)在生物学和基因组模式上存在差异,但炎症指标的变化尚未得到充分研究。本研究旨在探讨炎症指标在 RCC 和 LCC 之间的差异及其价值。

方法:在训练队列中,使用逻辑回归模型分析 LCC 和 RCC 之间常见临床病理因素和炎症指标(包括血小板淋巴细胞比值[PLR])的差异,随后在验证队列中进行验证。采用 Kaplan-Meier 分析比较 PLR 区分的生存差异,采用非参数检验比较 RCC 和 LCC 中 PLR 变化与标准 TNM 分期的差异。

结果:共纳入 1846 例 CRC 患者,其中 744 例(40.3%)为 RCC,1102 例(59.7%)为 LCC。两个队列的患者数量均为 923 例。研究发现,训练队列中 LCC 患者的 CEA、腺癌、早期 UICC/AJCC 分期、p-MMR(错配修复功能正常)更高,PLR 更低,且后四个特征在验证队列中得到了验证。在 LCC 队列中,较高的 PLR(唯一的炎症指标)与较差的 OS 显著相关(P=0.002),并且在 LCC 患者中与 TNM 分期升高相关(P<0.001),但这两个关系在 RCC 患者中并不成立。

结论:除了经典特征外,PLR 是一种廉价且易于评估的炎症指标,首次发现其在 LCC 和 RCC 之间存在显著差异。此外,PLR 升高与 LCC 的 OS 不良(总体生存)相关,并且更常见于晚期 TNM 分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf9/5738180/6e9e5d8ca949/12885_2017_3862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf9/5738180/292865b2da8c/12885_2017_3862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf9/5738180/6e9e5d8ca949/12885_2017_3862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf9/5738180/292865b2da8c/12885_2017_3862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf9/5738180/6e9e5d8ca949/12885_2017_3862_Fig2_HTML.jpg

相似文献

[1]
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

BMC Cancer. 2017-12-20

[2]
[Effects of tumor location and mismatch repair on clinicopathological features and survival for non-metastatic colon cancer: A retrospective, single center, cohort study].

Zhonghua Wei Chang Wai Ke Za Zhi. 2024-6-25

[3]
Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study.

Arch Med Res. 2019-6-14

[4]
Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.

World J Gastroenterol. 2024-9-7

[5]
Different treatment strategies and molecular features between right-sided and left-sided colon cancers.

World J Gastroenterol. 2015-6-7

[6]
Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.

J Clin Lab Anal. 2020-4

[7]
Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer.

Clin Colorectal Cancer. 2018-7-5

[8]
Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.

Dig Surg. 2016

[9]
Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.

Int J Surg. 2023-8-1

[10]
The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.

Cancer Med. 2021-5

引用本文的文献

[1]
Identification of predictors for lymph node metastasis in T2 colorectal cancer: retrospective cohort study from a high-volume hospital.

BMC Cancer. 2025-4-15

[2]
Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy.

Front Oncol. 2023-5-12

[3]
Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer.

Front Oncol. 2023-3-29

[4]
A Retrospective Study from a Single Center to Identify Hematological Factors that Distinguish Between Patients with Colorectal Carcinoma and Colorectal Adenoma.

Med Sci Monit. 2022-8-10

[5]
The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis.

Transl Cancer Res. 2020-9

[6]
High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.

Cancer Cell Int. 2021-4-13

[7]
Tumor-infiltrating lymphocytes in tissue material combined with systemic lymphocyte inflammation in patients with colorectal cancer.

Mol Clin Oncol. 2021-5

[8]
Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.

J Clin Lab Anal. 2020-4

[9]
The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.

J Transl Med. 2018-10-4

本文引用的文献

[1]
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer.

Sci Rep. 2017-5-4

[2]
Preoperative Prognostic Nutritional Index Correlates with Severe Complications and Poor Survival in Patients with Colorectal Cancer Undergoing Curative Laparoscopic Surgery: A Retrospective Study in a Single Chinese Institution.

Nutr Cancer. 2017-4

[3]
Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.

World J Gastroenterol. 2017-1-21

[4]
The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.

Sci Rep. 2016-10-5

[5]
Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.

J Clin Lab Anal. 2017-9

[6]
Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.

PLoS One. 2016-9-22

[7]
Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.

Oncotarget. 2016-6-14

[8]
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Cancer Discov. 2016-6

[9]
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.

Clin Colorectal Cancer. 2016-6

[10]
Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.

Eur J Cancer Care (Engl). 2017-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索